Back

Modified mRNA delivery to the heart using Lipid Nanoparticles

30 April 2022 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Novelties in cardiovascular disease mechanism Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Maria Clara Isabel Labonia

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Intravital & laser speckle investigations of the role of interleukin36 in myocardial ischaemia reperfusion injury; a new therapeutic target for the aged heart
Mr J. El-Awaisi (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Effective revascularization of non-healing wounds by the human Stromal Vascular Fraction relies on direct cell integration and paracrine signals
Mr R. Vuerich (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Doxorubicin induces measurable vascular toxicity: assessment in a clinical and preclinical study
Mr M. Bosman (Antwerp, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Novelties in cardiovascular disease mechanism
Video

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Effective cardiac mRNA delivery using lipid nanoparticles
27 August 2023
thumbnail
Congress Presentation
Macrophage depletion impairs adequate cardiac repair in mouse models of myocardial infarction with variable transmurality - insights from multimodality molecular imaging
9 May 2021
thumbnail
Congress Presentation
Therapeutic potential of extracellular vesicle-mediated miRNA delivery based on liver-heart crosstalk for cardiac injury
29 August 2025
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources